Mieke D. Trip
About
Mieke D. Trip is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Mieke D. Trip has authored 70 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 17 papers in Cardiology and Cardiovascular Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mieke D. Trip's work include Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Cholesterol and Lipid Metabolism (7 papers). Mieke D. Trip is often cited by papers focused on Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Cholesterol and Lipid Metabolism (7 papers). Mieke D. Trip collaborates with scholars based in Netherlands, United States and United Kingdom. Mieke D. Trip's co-authors include John J.P. Kastelein, V. Manger Cats, Frans J.L. van Capelle, Wilmar M. Wiersinga, Maud N. Vissers, Tineke J. Smilde, Erik S.G. Stroes, Sanne van Wissen, Aeilko H. Zwinderman and Eric J.G. Sijbrands and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.
In The Last Decade
Mieke D. Trip
70 papers receiving 3.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mieke D. Trip Netherlands | 33 | 1.8k | 1.2k | 1.0k | 723 | 578 | 70 | 3.6k | ||
| Masa‐aki Kawashiri Japan | 35 | 2.4k 1.4× | 1.5k 1.3× | 1.2k 1.2× | 925 1.3× | 714 1.2× | 286 | 4.6k | ||
| Atsushi Nohara Japan | 37 | 2.5k 1.4× | 1.1k 1.0× | 1.3k 1.3× | 877 1.2× | 889 1.5× | 178 | 4.3k | ||
| Rui‐Xia Xu China | 33 | 1.7k 1.0× | 1.0k 0.9× | 714 0.7× | 785 1.1× | 630 1.1× | 158 | 3.5k | ||
| Hirofumi Soejima Japan | 35 | 948 0.5× | 2.0k 1.7× | 631 0.6× | 652 0.9× | 356 0.6× | 126 | 3.9k | ||
| G. Dahlén Sweden | 27 | 2.3k 1.3× | 991 0.8× | 1.4k 1.4× | 349 0.5× | 929 1.6× | 64 | 3.8k | ||
| G M Fless United States | 23 | 2.1k 1.2× | 648 0.5× | 850 0.8× | 649 0.9× | 1.2k 2.0× | 32 | 3.1k | ||
| Dov Gavish Israel | 26 | 1.1k 0.6× | 714 0.6× | 787 0.8× | 371 0.5× | 386 0.7× | 70 | 2.7k | ||
| Cheng‐Gang Zhu China | 31 | 2.0k 1.1× | 1.5k 1.3× | 1.2k 1.2× | 303 0.4× | 423 0.7× | 209 | 3.7k | ||
| Eak Kyun Shin South Korea | 31 | 1.3k 0.7× | 1.3k 1.1× | 1.1k 1.1× | 332 0.5× | 254 0.4× | 123 | 3.2k | ||
| Yuan‐Lin Guo China | 29 | 1.8k 1.0× | 1.2k 1.0× | 994 1.0× | 322 0.4× | 428 0.7× | 156 | 3.2k |
Countries citing papers authored by Mieke D. Trip
Since
Specialization
Citations
This map shows the geographic impact of Mieke D. Trip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke D. Trip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke D. Trip more than expected).
Fields of papers citing papers by Mieke D. Trip
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mieke D. Trip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke D. Trip. The network helps show where Mieke D. Trip may publish in the future.
Co-authorship network of co-authors of Mieke D. Trip
This figure shows the co-authorship network connecting the top 25 collaborators of Mieke D. Trip. A scholar is included among the top collaborators of Mieke D. Trip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke D. Trip. Mieke D. Trip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Iperen, Erik P.A. van, Suthesh Sivapalaratnam, S. Matthijs Boekholdt, et al.. (2013). Common genetic variants do not associate with CAD in familial hypercholesterolemia. European Journal of Human Genetics. 22(6). 809–813.
2.
Visser, Maartje E., Gilbert Wagener, Brenda F. Baker, et al.. (2012). Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial. European Heart Journal. 33(9). 1142–1149.
3.
Paul, Dirk S., James Nisbet, Tsun-Po Yang, et al.. (2011). Correction: Maps of Open Chromatin Guide the Functional Follow-Up of Genome-Wide Association Signals: Application to Hematological Traits. PLoS Genetics. 7(7).
4.
Sondermeijer, Brigitte M., Annemieke Bakker, Maurice W.J. de Ronde, et al.. (2011). Platelets in Patients with Premature Coronary Artery Disease Exhibit Upregulation of miRNA340* and miRNA624*. PLoS ONE. 6(10). e25946–e25946.
5.
Bogaard, Bas van den, Annemieke Bakker, Mieke D. Trip, et al.. (2011). Arterial stiffness is increased in families with premature coronary artery disease. Heart. 98(6). 490–494.
6.
Akdim, Fatima, Erik S.G. Stroes, Eric J.G. Sijbrands, et al.. (2010). Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. Journal of the American College of Cardiology. 55(15). 1611–1618.
7.
Wiersma, Jacobijne J., Hein J. Verberne, Marijn C. Meuwese, et al.. (2010). Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints. Clinica Chimica Acta. 412(1-2). 86–90.
8.
Kastelein, John J.P., Fatima Akdim, E.S.G. Stroes, et al.. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia (vol 358, pg 1431, 2008). New England Journal of Medicine. 358(18).
9.
Loo, Karen M. J. van, et al.. (2008). Male-Specific Association between a γ-Secretase Polymorphism and Premature Coronary Atherosclerosis. PLoS ONE. 3(11). e3662–e3662.
10.
Rana, Jamal S., Angelique C.M. Jansen, Aeilko H. Zwinderman, et al.. (2006). Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia. Diabetes Care. 29(5). 1125–1127.
11.
Jakulj, Lily, Maud N. Vissers, Jessica Rodenburg, et al.. (2006). Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. The Journal of Pediatrics. 148(4). 495–500.
12.
Wiersma, Jacobijne J., Hein J. Verberne, Mieke D. Trip, et al.. (2006). Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms. European Journal of Nuclear Medicine and Molecular Imaging. 33(12). 1468–1476.
13.
Wissen, Sanne van, Tineke J. Smilde, Mieke D. Trip, Anton F. H. Stalenhoef, & John J.P. Kastelein. (2005). Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. The American Journal of Cardiology. 95(2). 264–266.
14.
Netea, Mihai G., Anneke Hijmans, Sanne van Wissen, et al.. (2004). Toll‐like receptor‐4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. European Journal of Clinical Investigation. 34(2). 94–99.
15.
Nolting, Pernette R. W. de Sauvage, et al.. (2003). Regression of Carotid and Femoral Artery Intima-Media Thickness in Familial Hypercholesterolemia. Archives of Internal Medicine. 163(15). 1837–1837.
16.
Wissen, Sanne van, Mieke D. Trip, Tineke J. Smilde, et al.. (2002). Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis. 165(2). 361–366.
17.
Lombardi, Maria, Joep C. Defesche, Sylvia W.A. Kamerling, et al.. (2000). Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the Netherlands. Clinical Genetics. 57(2). 116–124.
18.
Smilde, Tineke J., Mieke D. Trip, Hub Wollersheim, et al.. (2000). Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia. Clinical Drug Investigation. 20(2). 67–79.
19.
Franco, Rendrik F., Mieke D. Trip, Hugo Ten Cate, et al.. (1999). The 20210 G → A mutation in the 3′‐untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. British Journal of Haematology. 104(1). 50–54.
20.
Verhoeff, Bart‐Jan, Mieke D. Trip, Maria Prins, John J.P. Kastelein, & Pieter H. Reitsma. (1998). The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis. 141(1). 161–166.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Masa‐aki Kawashiri Breakdown of academic impact, for papers by Atsushi Nohara Breakdown of academic impact, for papers by Rui‐Xia Xu Breakdown of academic impact, for papers by Hirofumi Soejima Breakdown of academic impact, for papers by G. Dahlén Breakdown of academic impact, for papers by G M Fless Breakdown of academic impact, for papers by Dov Gavish Breakdown of academic impact, for papers by Cheng‐Gang Zhu Breakdown of academic impact, for papers by Eak Kyun Shin Breakdown of academic impact, for papers by Yuan‐Lin Guo